ODDO, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 839
NA - Nord America 683
AS - Asia 104
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 2
Totale 1.637
Nazione #
US - Stati Uniti d'America 681
IE - Irlanda 504
SE - Svezia 285
IN - India 52
CN - Cina 42
IT - Italia 36
EU - Europa 9
NL - Olanda 4
GB - Regno Unito 3
LK - Sri Lanka 3
FI - Finlandia 2
SV - El Salvador 2
TN - Tunisia 2
BD - Bangladesh 1
CZ - Repubblica Ceca 1
DE - Germania 1
DK - Danimarca 1
FR - Francia 1
IL - Israele 1
JP - Giappone 1
KZ - Kazakistan 1
MY - Malesia 1
RO - Romania 1
SG - Singapore 1
VN - Vietnam 1
Totale 1.637
Città #
Dublin 504
Nyköping 278
Ashburn 109
Chandler 86
Princeton 86
Medford 85
Des Moines 64
Pune 46
Messina 21
Wilmington 14
Jiaxing 8
Jinan 7
Ningbo 6
Hyderabad 5
Norwalk 5
New York 4
San Francisco 4
Taizhou 4
Augusta 3
Brooklyn 3
Catania 3
Kaduwela 3
Los Angeles 3
Nanjing 3
Bari 2
Manchester 2
Nanchang 2
Redmond 2
San Salvador 2
Zhengzhou 2
Bremen 1
Brno 1
Catanzaro 1
Copenhagen 1
Haikou 1
Hebei 1
Hunedoara 1
Karaganda 1
Las Vegas 1
London 1
Milan 1
Shenyang 1
Taiyuan 1
Tianjin 1
Tsukuba 1
Yicheng 1
Totale 1.382
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 63
The ubiquitin-proteasome system in Alzheimer‘s disease 38
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders 36
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer‘s disease 32
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease 31
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice 31
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aß oligomers accumulation 30
Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease 30
BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer‘s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology 29
Autophagic/lysosomal dysfunction in Alzheimer's disease 29
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome 29
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD 29
Administration of a selective beta 2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease 28
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice 28
Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer‘s disease 25
beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models 25
Alzheimer's disease: Abeta, tau and synaptic dysfunction 25
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer‘s disease 25
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology 23
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits 21
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles 20
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease 20
Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles 20
A dynamic relationship between intracellular and extracellular pools of Abeta 20
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits 20
Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canine 20
Increased intraneuronal resting [Ca2+] in adult Alzheimer‘s disease mice 19
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature 19
null 18
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study 18
Congo red and thioflavin-T analogs detect Abeta oligomers 18
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer‘s disease mice 18
Intracellular amyloid-beta in Alzheimer‘s disease 18
Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia 18
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology 18
A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip 17
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology 17
Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology 17
Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice 17
Validation of a 2-day water maze protocol in mice 17
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer‘s disease 17
Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer‘s mouse models 17
Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle 17
Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice 17
Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism 17
Triple-transgenic model of Alzheimer‘s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction 17
Intraneuronal Abeta causes the onset of early Alzheimer‘s disease-related cognitive deficits in transgenic mice 17
M1 receptors play a central role in modulating AD-like pathology in transgenic mice 17
Genetic suppression of beta 2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies 17
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology 16
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice 16
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice 16
Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer‘s disease 16
Modeling behavioral and neuronal symptoms of Alzheimer‘s disease in mice: a role for intraneuronal amyloid 16
Toxic role of K+ channel oxidation in mammalian brain 16
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer‘s disease 16
null 15
The role of nicotinic acetylcholine receptors in Alzheimer‘s disease 15
Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice 15
The Collagen Chaperone HSP47 Is a New Interactor of APP that Affects the Levels of Extracellular Beta-Amyloid Peptides 15
Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity 15
Oxidative Damage and Amyloid-beta Metabolism in Brain Regions of the Longest-Lived Rodents 15
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease 15
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice 15
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer‘s disease 15
Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and NMDA signaling 15
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? 14
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments 14
Inhibition of soluble TNF signaling in a mouse model of Alzheimer‘s disease prevents pre-plaque amyloid-associated neuropathology 14
Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease 14
Neural stem cells improve memory in an inducible mouse model of neuronal loss 14
Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease 13
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer‘s disease progression 13
mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease 13
Paving the Way for New Clinical Trials for Alzheimer's Disease 13
Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability 13
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story 13
Cognitive decline typical of FTLD in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43 13
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease 12
Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43 12
Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease 12
Glucocorticoids Exacerbate Cognitive Deficits in TDP-25 Transgenic Mice via a Glutathione-Mediated Mechanism: Implications for Aging, Stress and TDP-43 Proteinopathies 12
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease 12
Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer‘s disease 12
Dyrk1 inhibition improves Alzheimer's disease-like pathology 12
Multipotential Role of Growth Factor Mimetic Peptides for Osteochondral Tissue Engineering 11
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies 11
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease 11
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways 11
The role of mTOR signaling in Alzheimer disease 10
Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice 10
The Role of miR-128 in Neurodegenerative Diseases 7
Necroptosis activation in Alzheimer's disease 6
Physiologic Response Evaluation of Human Foetal Osteoblast Cells within Engineered 3D-Printed Polylactic Acid Scaffolds 6
Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations 6
Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders 4
Generation of a helper phage for the fluorescent detection of peptide-target interactions by dual-display phages 4
Silicon‐Based Sensing Surface for Alzheimer's Disease Diagnosis by Phages Probes 4
The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities 3
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 3
Totale 1.743
Categoria #
all - tutte 12.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.262

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 92 0
2021/2022326 9 0 0 1 5 4 41 22 5 0 3 236
2022/20231.035 107 67 48 22 36 100 21 50 552 4 22 6
2023/2024293 6 26 15 104 10 58 0 10 22 24 18 0
Totale 1.746